New myeloma drugs improve response and extend survival

K. Anderson
{"title":"New myeloma drugs improve response and extend survival","authors":"K. Anderson","doi":"10.12788/JCSO.0376","DOIUrl":null,"url":null,"abstract":"DR HENRY I thought we might discuss some cases of patients with myeloma, starting with a relatively simple case and ending with one that is a little more complicated. For the first case, we have a 56-yearold healthy man with IgG kappa myeloma whose work-up shows he has multiple lytic bone lesions. He has normal renal function, normal calcium, and he’s transplanteligible by other health issues. I’ll leave the cytogenetics up to you if that changes your approach. How would you develop or pose some options for this man’s treatment to begin with?","PeriodicalId":75058,"journal":{"name":"The Journal of community and supportive oncology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of community and supportive oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12788/JCSO.0376","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

DR HENRY I thought we might discuss some cases of patients with myeloma, starting with a relatively simple case and ending with one that is a little more complicated. For the first case, we have a 56-yearold healthy man with IgG kappa myeloma whose work-up shows he has multiple lytic bone lesions. He has normal renal function, normal calcium, and he’s transplanteligible by other health issues. I’ll leave the cytogenetics up to you if that changes your approach. How would you develop or pose some options for this man’s treatment to begin with?
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
新的骨髓瘤药物改善反应并延长生存期
亨利医生我想我们可以讨论一些骨髓瘤患者的病例,从一个相对简单的病例开始,到一个稍微复杂一点的病例结束。在第一个病例中,我们有一名56岁的健康男性,患有IgGκ骨髓瘤,他的检查显示他有多发性溶解性骨损伤。他的肾功能正常,钙含量正常,还有其他健康问题,可以移植。如果这改变了你的方法,我将把细胞遗传学留给你。你会如何为这个男人的治疗制定或提出一些选择?
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Mortality outcomes in hospitalized oncology patients after rapid response team activation Development, implementation, and evaluation of a prostate cancer supportive care program Comparing risk models guiding growth factor use in chemotherapy Effectiveness of duloxetine in treatment of painful chemotherapy-induced peripheral neuropathy: a systematic review Symptom burdens related to chemotherapy-induced anemia in stage IV cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1